Results 181 to 190 of about 16,509 (232)
Some of the next articles are maybe not open access.
HLA-A*33:03-Restricted Activation of Ticlopidine-Specific T-Cells from Human Donors.
Chemical Research in Toxicology, 2018The HLA class I allele HLA-A*33:03 is a risk factor for ticlopidine-induced liver injury. Herein, we show HLA class I-restricted ticlopidine-specific CD8+ T-cell activation in healthy donors expressing HLA-A*33:03.
Toru Usui +8 more
semanticscholar +1 more source
Journal of Neuroscience Nursing, 1992
Ticlopidine, a new prototype antiplatelet agent, offers a significant alternative in the primary and secondary prevention of atherothrombotic stroke. While 2 multicenter trials demonstrated benefits of ticlopidine, this drug is not without risks and limitations and more studies are indicated.
openaire +2 more sources
Ticlopidine, a new prototype antiplatelet agent, offers a significant alternative in the primary and secondary prevention of atherothrombotic stroke. While 2 multicenter trials demonstrated benefits of ticlopidine, this drug is not without risks and limitations and more studies are indicated.
openaire +2 more sources
Journal of Biomolecular Structure and Dynamics, 2019
Shumaila Afrin +2 more
semanticscholar +1 more source
Shumaila Afrin +2 more
semanticscholar +1 more source
Spectrochimica Acta Part A - Molecular and Biomolecular Spectroscopy, 2017
Shumaila Afrin +6 more
semanticscholar +1 more source
Shumaila Afrin +6 more
semanticscholar +1 more source
Journal of Chemical Thermodynamics, 2019
S. Khatun, Riyazuddeen, G. Rabbani
semanticscholar +1 more source
S. Khatun, Riyazuddeen, G. Rabbani
semanticscholar +1 more source